Clinical research - Press Releases

Date	Title	Company
13-Apr-2022	CD BioSciences Introduces GPCR Drug Discovery Services	CD BioSciences
13-Apr-2022	CD Bioparticles Launches Organic Gold Nanorods for Research Use	CD Bioparticles
13-Apr-2022	Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies	Creative Diagnostics
13-Apr-2022	Amerigo Scientific Launches 2',3'-Diacetyl Guanosine (n-ibu)	Amerigo Scientific
12-Apr-2022	Priothera Receives First Regulatory Approvals to Start a Global Pivotal Study with Mocravimod in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant	Priothera
12-Apr-2022	Dante Labs announces ventures into biosimulation and drug discovery, demonstrating the predictive value of the Dante Platform	Dante Labs
12-Apr-2022	AlzeCure carries out a set-off issue in connection with ACD440 entering phase II and Acturum Life investing in the company	AlzeCure
12-Apr-2022	Nouscom Announces New Translational Phase 1 Data of NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine for the Treatment of MSI-H Solid Tumors, at AACR 2022	Nouscom
12-Apr-2022	European Patent Granted for Sareum’s SDC-1802, a Novel Small Molecule TYK2/JAK1 Inhibitor, for the Treatment of T-cell Acute Lymphoblastic Leukaemia	Sareum Holdings
12-Apr-2022	Cline successfully completes first stage of StemCART ex-vivo testing on human cartilage	Cline Scientific
12-Apr-2022	Revolutionary UK machine learning biotech firm agrees deal to develop new cancer treatments	Etcembly
12-Apr-2022	Qlucore makes strategic recruitment for the clinical market	Qlucore
12-Apr-2022	Early cancer diagnostic test, the Cytosponge, receives ACG backing for the screening of Barrett’s Esophagus	Cytosponge
11-Apr-2022	CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities	CluePoints
11-Apr-2022	Abzena Opens a New Biologics Testing Lab to Support Partners Programs	Abzena
07-Apr-2022	STEMart Introduces Acute Systemic Toxicity Testing Service for Medical Devices	STEMart
07-Apr-2022	CD BioSciences Launches Metabolic Signaling Pathways for Research Use	CD BioSciences
06-Apr-2022	FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA	SMi Group
06-Apr-2022	Early access issued for eligible patients in the UK for radioligand therapy in advanced prostate cancer	Advanced Accelerator Applications (AAA), a Novartis company.
05-Apr-2022	Achilles Therapeutics to Host KOL Webcast to Highlight TRACERx Study Presentations from the 2022 AACR Annual Meeting	Achilles Therapeutics